| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |